Fwd: [drugawareness] FORBES: FDA EVALUATING DATA ON GSK's SEROXAT [PAXIL]

[Guest guest]

atracyphd2

Tue, 10 Jun 2003 12:29:34 EDT

[drugawareness] FORBES: FDA EVALUATING DATA ON GSK's SEROXAT [PAXIL]

 

 

 

 

How amazing that the regulatory agency which approved Prozac for the use of

children in January of this year would now reconsider after seeing the United

Kingdom beat them to the punch when it comes to warning about the dangers of

SSRIs among children and adolescents! If anyone in America thinks they are

protected by the FDA, they had better think again!

 

The number of Paxil and other SSRI related suicides, murder/suicides and mass

killings by minors in this country alone is beyond belief at this point! I

cannot even begin to keep up with the cases.

 

 

Dr. Ann Blake Tracy, Executive Director,

International Coalition For Drug Awareness

www.drugawareness.org & author of Prozac:

Panacea or Pandora? - Our Serotonin Nightmare

(800-280-0730)

 

________________________________

 

 

http://www.forbes.com/home_europe/newswire/2003/06/10/rtr995154.html

 

UK says U.S. FDA evaluating data on GSK's Seroxat

 

Reuters, 06.10.03, 5:59 AM ET

 

 

LONDON, June 10 (Reuters) - Britain's drug regulatory agency said on Tuesday

the U.S. Food and Drug Administration was evaluating data on GlaxoSmithKline

Plc's <GSK.L> antidepressant Seroxat after the UK warned it should not be given

to children.

 

Medicines and Healthcare products Regulatory Authority (MHRA) officials,

addressing a news conference, said Europe's CPMP expert committee on medicines

had

also been alerted.

 

The MHRA recommended Seroxat should not be used to treat depression in people

under 18 after new data showed an increase in the rate of self-harm and

suicidal tendencies in those taking the drug in this age group.

 

Copyright 2003, Reuters News Service